[
  {
    "title": "太龙药业(600222.SH)：第二期员工持股计划股票出售完毕暨终止",
    "href": "http://stock.jrj.com.cn/2023/01/06162137264350.shtml",
    "datetime": "2023-01-06 16:21:40",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：12月未进行股份回购",
    "href": "http://stock.jrj.com.cn/2023/01/03160837255322.shtml",
    "datetime": "2023-01-03 16:08:33",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业12月19日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/19181337223179.shtml",
    "datetime": "2022-12-19 18:13:25",
    "code": "600222"
  },
  {
    "title": "太龙药业副董事长李辉辞职 2021年薪酬为165.87万",
    "href": "http://stock.jrj.com.cn/2022/12/16201237219349.shtml",
    "datetime": "2022-12-16 20:12:27",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业12月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/14181837212610.shtml",
    "datetime": "2022-12-14 18:18:03",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业12月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/12181637206548.shtml",
    "datetime": "2022-12-12 18:16:45",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：股东吴澜拟减持不超1.22%股份",
    "href": "http://stock.jrj.com.cn/2022/12/09173937202068.shtml",
    "datetime": "2022-12-09 17:39:10",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：11月未进行股份回购",
    "href": "http://stock.jrj.com.cn/2022/11/30161837178207.shtml",
    "datetime": "2022-11-30 16:18:26",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：累计收到政府补助318.897万元",
    "href": "http://stock.jrj.com.cn/2022/11/30161737178210.shtml",
    "datetime": "2022-11-30 16:17:21",
    "code": "600222"
  },
  {
    "title": "中药板块走强，太龙药业、特一药业涨停",
    "href": "http://stock.jrj.com.cn/2022/11/29095737173286.shtml",
    "datetime": "2022-11-29 09:57:06",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业11月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/25180537167528.shtml",
    "datetime": "2022-11-25 18:05:13",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业11月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/24180637164349.shtml",
    "datetime": "2022-11-24 18:06:24",
    "code": "600222"
  },
  {
    "title": "医药板块大幅走低，华森制药、特一药业、太龙药业跌停",
    "href": "http://stock.jrj.com.cn/2022/11/23094137159676.shtml",
    "datetime": "2022-11-23 09:41:11",
    "code": "600222"
  },
  {
    "title": "最新龙虎榜：机构买入隆扬电子超6000万元，知名游资买入太龙药业",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/23071837159345.shtml",
    "datetime": "2022-11-23 07:18:50",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业11月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/22180637158148.shtml",
    "datetime": "2022-11-22 18:06:33",
    "code": "600222"
  },
  {
    "title": "龙虎榜：沪深港通净卖出1.42亿元双星新材，方新侠转战太龙药业",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/22173937157943.shtml",
    "datetime": "2022-11-22 17:39:43",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：第三期员工持股计划完成股票非交易过户",
    "href": "http://stock.jrj.com.cn/2022/11/22170937157798.shtml",
    "datetime": "2022-11-22 17:09:09",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业11月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/21180737154932.shtml",
    "datetime": "2022-11-21 18:07:11",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业11月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/18180737150705.shtml",
    "datetime": "2022-11-18 18:07:34",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业11月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/17180637147357.shtml",
    "datetime": "2022-11-17 18:06:21",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：拟与间接控股股东共同投设龙华医药产业基金",
    "href": "http://stock.jrj.com.cn/2022/11/10173637128084.shtml",
    "datetime": "2022-11-10 17:36:50",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：截至10月底已累计回购1.25%股份",
    "href": "http://stock.jrj.com.cn/2022/11/01153837103133.shtml",
    "datetime": "2022-11-01 15:38:42",
    "code": "600222"
  },
  {
    "title": "太龙药业2022年前三季度亏损5687.83万同比由盈转亏 成本费用支出增长",
    "href": "http://stock.jrj.com.cn/2022/10/28211137095649.shtml",
    "datetime": "2022-10-28 21:11:45",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：已累计回购1.01%的股份",
    "href": "http://stock.jrj.com.cn/2022/09/26153837021438.shtml",
    "datetime": "2022-09-26 15:38:13",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)截至8月底已累计回购217.99万股",
    "href": "http://stock.jrj.com.cn/2022/08/31154136958085.shtml",
    "datetime": "2022-08-31 15:41:05",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)及子公司累计获得政府补助276.26万元",
    "href": "http://stock.jrj.com.cn/2022/08/31153936957994.shtml",
    "datetime": "2022-08-31 15:39:20",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：上半年净亏损2543.23万元",
    "href": "http://stock.jrj.com.cn/2022/08/19173736916744.shtml",
    "datetime": "2022-08-19 17:37:34",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：首次回购28.58万股 涉资154.686万元",
    "href": "http://stock.jrj.com.cn/2022/08/03164436867018.shtml",
    "datetime": "2022-08-03 16:44:57",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)尚未实施股份回购",
    "href": "http://stock.jrj.com.cn/2022/08/01170636859569.shtml",
    "datetime": "2022-08-01 17:06:29",
    "code": "600222"
  },
  {
    "title": "太龙药业将花不超8000万元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2022/07/20195136829648.shtml",
    "datetime": "2022-07-20 19:51:56",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：拟回购4000万元-8000万元的公司股份",
    "href": "http://stock.jrj.com.cn/2022/07/14212436813033.shtml",
    "datetime": "2022-07-14 21:24:40",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：半年度预亏2600万元左右",
    "href": "http://stock.jrj.com.cn/2022/07/14181836812135.shtml",
    "datetime": "2022-07-14 18:18:09",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)成为藿香正气合剂、板蓝根糖浆等的上市许可持有人",
    "href": "http://stock.jrj.com.cn/2022/07/11161936799016.shtml",
    "datetime": "2022-07-11 16:19:37",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)2021年度权益分派10派0.1元 股权登记日为7月7日",
    "href": "http://stock.jrj.com.cn/2022/06/30164836771753.shtml",
    "datetime": "2022-06-30 16:48:21",
    "code": "600222"
  },
  {
    "title": "太龙药业：中国研究型医院学会达成战略合作协议",
    "href": "http://stock.jrj.com.cn/2022/06/17105236737157.shtml",
    "datetime": "2022-06-17 10:52:51",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：与研究型医院学会签署战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2022/06/16173936735102.shtml",
    "datetime": "2022-06-16 17:39:37",
    "code": "600222"
  },
  {
    "title": "太龙药业：与中国研究型医院学会签署战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2022/06/16173936735099.shtml",
    "datetime": "2022-06-16 17:39:32",
    "code": "600222"
  },
  {
    "title": "太龙药业2021年净利599.54万同比下滑79.5% 总经理罗剑超薪酬116.12万",
    "href": "http://stock.jrj.com.cn/2022/04/20201236412217.shtml",
    "datetime": "2022-04-20 20:12:33",
    "code": "600222"
  },
  {
    "title": "太龙药业：年初至今累计获得政府补助239.09万元",
    "href": "http://stock.jrj.com.cn/2022/04/20171736410844.shtml",
    "datetime": "2022-04-20 17:17:25",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：累计收到政府补助共239.09万元",
    "href": "http://stock.jrj.com.cn/2022/04/20161036409876.shtml",
    "datetime": "2022-04-20 16:10:32",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：拟推第三期员工持股计划 筹资上限为4900万元",
    "href": "http://stock.jrj.com.cn/2022/04/19193036401470.shtml",
    "datetime": "2022-04-19 19:30:35",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：2021年净利降79.50%至599.54万元 拟10派0.1元",
    "href": "http://stock.jrj.com.cn/2022/04/19192736401417.shtml",
    "datetime": "2022-04-19 19:27:18",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业3月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/24180634913957.shtml",
    "datetime": "2022-03-24 18:06:54",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：接受间接控股股东不超12亿元财务支持",
    "href": "http://stock.jrj.com.cn/2022/03/23163534867917.shtml",
    "datetime": "2022-03-23 16:35:40",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：子公司拟出资3000万元参投无锡金宜基金",
    "href": "http://stock.jrj.com.cn/2022/02/15171934354242.shtml",
    "datetime": "2022-02-15 17:19:26",
    "code": "600222"
  },
  {
    "title": "太龙药业2021年预计净利500万同比减少82% 全资子公司部分存货毁损变质",
    "href": "http://stock.jrj.com.cn/2022/01/29141134257021.shtml",
    "datetime": "2022-01-29 14:11:03",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：2021年度净利预减82%左右",
    "href": "http://stock.jrj.com.cn/2022/01/28220234250927.shtml",
    "datetime": "2022-01-28 22:02:45",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：公司实控人变更为郑州高新技术产业开发区管委会",
    "href": "http://stock.jrj.com.cn/2022/01/24163034204560.shtml",
    "datetime": "2022-01-24 16:30:52",
    "code": "600222"
  },
  {
    "title": "太龙药业拟投资5000万设立全资子公司太龙本草",
    "href": "http://stock.jrj.com.cn/2022/01/19201234175390.shtml",
    "datetime": "2022-01-19 20:12:04",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：拟出资5000万元在云南设立全资子公司太龙本草",
    "href": "http://stock.jrj.com.cn/2022/01/19171934174522.shtml",
    "datetime": "2022-01-19 17:19:59",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：自4月1日累计收到政府补助259.63万元",
    "href": "http://stock.jrj.com.cn/2021/12/27170534071179.shtml",
    "datetime": "2021-12-27 17:05:43",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：第一期员工持股计划股票出售完毕暨终止",
    "href": "http://stock.jrj.com.cn/2021/12/13164034008829.shtml",
    "datetime": "2021-12-13 16:40:14",
    "code": "600222"
  },
  {
    "title": "太龙药业布局CRO子公司创利2.26亿 郑州国资8亿入主将推全产业链搭建",
    "href": "http://stock.jrj.com.cn/2021/12/01070933947826.shtml",
    "datetime": "2021-12-01 07:09:44",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业11月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/11/30180833945097.shtml",
    "datetime": "2021-11-30 18:08:23",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：众生实业拟将14.37%股份转让予泰容产投 控股股东将变更为泰容产投",
    "href": "http://stock.jrj.com.cn/2021/11/29161833938130.shtml",
    "datetime": "2021-11-29 16:18:54",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)第三季度净利润111.75万元 同比增长170.59%",
    "href": "http://stock.jrj.com.cn/2021/10/29201933779600.shtml",
    "datetime": "2021-10-29 20:19:55",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业9月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/09/27181033524820.shtml",
    "datetime": "2021-09-27 18:10:53",
    "code": "600222"
  },
  {
    "title": "太龙药业或易主郑州国资打造行业龙头 增收难增利药品研发服务利润占近58%",
    "href": "http://stock.jrj.com.cn/2021/09/24071333508239.shtml",
    "datetime": "2021-09-24 07:13:34",
    "code": "600222"
  },
  {
    "title": "太龙药业拟迎新主，郑州高新产投拟成实控人",
    "href": "http://stock.jrj.com.cn/2021/09/23115433503852.shtml",
    "datetime": "2021-09-23 11:54:18",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：实控人将变更为郑州高新技术产业开发区管委会 明起复牌",
    "href": "http://stock.jrj.com.cn/2021/09/22193633499979.shtml",
    "datetime": "2021-09-22 19:36:55",
    "code": "600222"
  },
  {
    "title": "太龙药业：控股股东正在筹划重大事项 17日起停牌",
    "href": "http://stock.jrj.com.cn/2021/09/16165533445591.shtml",
    "datetime": "2021-09-16 16:55:53",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：控股股东筹划重大事项 明起停牌",
    "href": "http://stock.jrj.com.cn/2021/09/16165033445583.shtml",
    "datetime": "2021-09-16 16:50:50",
    "code": "600222"
  },
  {
    "title": "【龙虎榜】太龙药业9月10日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/09/10180633416166.shtml",
    "datetime": "2021-09-10 18:06:53",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：上半年净利增1.62%至2718.16万元",
    "href": "http://stock.jrj.com.cn/2021/08/27203633335763.shtml",
    "datetime": "2021-08-27 20:36:53",
    "code": "600222"
  },
  {
    "title": "太龙药业2021年半年度净利2718.16万元 同比净利增加1.62%",
    "href": "http://stock.jrj.com.cn/2021/08/27175233334337.shtml",
    "datetime": "2021-08-27 17:52:09",
    "code": "600222"
  },
  {
    "title": "太龙药业全资子公司的控股子公司拟投资3000万设立全资子公司维先医药",
    "href": "http://stock.jrj.com.cn/2021/08/23220233305392.shtml",
    "datetime": "2021-08-23 22:02:34",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)： 母公司两个主要生产厂区受严重汛情影响 暂无法核定损失",
    "href": "http://stock.jrj.com.cn/2021/07/22180933136161.shtml",
    "datetime": "2021-07-22 18:09:25",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：将金竹商贸4.7%的国有股权无偿划转至河南省财政厅",
    "href": "http://stock.jrj.com.cn/2021/06/09181932900666.shtml",
    "datetime": "2021-06-09 18:19:18",
    "code": "600222"
  },
  {
    "title": "太龙药业：公司间接持有贝泰妮股票所享有的权益按公允价值在报表其他权益工具投资、其他综合收益项目中列示",
    "href": "http://stock.jrj.com.cn/2021/05/24145432810341.shtml",
    "datetime": "2021-05-24 14:54:06",
    "code": "600222"
  },
  {
    "title": "太龙药业：公司业务包含药品制造、药品研发服务和药品药材流通等板块",
    "href": "http://stock.jrj.com.cn/2021/05/13070832745963.shtml",
    "datetime": "2021-05-13 07:08:57",
    "code": "600222"
  },
  {
    "title": "太龙药业2020年净利2924.09万下滑34.16% 董事长李景亮薪酬109.58万",
    "href": "http://stock.jrj.com.cn/2021/04/28105832469896.shtml",
    "datetime": "2021-04-28 10:58:48",
    "code": "600222"
  },
  {
    "title": "太龙药业：公司持有太龙健康80.4%股权",
    "href": "http://stock.jrj.com.cn/2021/03/24154132208593.shtml",
    "datetime": "2021-03-24 15:41:05",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)：第二期员工持股计划完成股票非交易过户",
    "href": "http://stock.jrj.com.cn/2021/02/09163031877726.shtml",
    "datetime": "2021-02-09 16:30:16",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)完成收购太龙健康33.95%股权及京港基金3.33%财产份额",
    "href": "http://stock.jrj.com.cn/2021/01/21155231736894.shtml",
    "datetime": "2021-01-21 15:52:57",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)及控股子公司通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2021/01/15155531698614.shtml",
    "datetime": "2021-01-15 15:55:14",
    "code": "600222"
  },
  {
    "title": "太龙药业：太龙健康作为太龙金茂的有限合伙人，不直接参与太龙金茂投资项目的经营管理",
    "href": "http://stock.jrj.com.cn/2020/12/21181431537638.shtml",
    "datetime": "2020-12-21 18:14:27",
    "code": "600222"
  },
  {
    "title": "太龙药业1.3亿元现金关联收购 标的一亏再亏遭问询",
    "href": "http://stock.jrj.com.cn/2020/12/02174931393620.shtml",
    "datetime": "2020-12-02 17:49:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：拟以现金支付方式收购太龙健康33.95%股权 收购价格为1.28亿元",
    "href": "http://stock.jrj.com.cn/2020/11/30204131378215.shtml",
    "datetime": "2020-11-30 20:41:12",
    "code": "600222"
  },
  {
    "title": "太龙药业前三季度净利2949.99万下滑10.37% 对外捐赠增加所致",
    "href": "http://stock.jrj.com.cn/2020/11/01173431184377.shtml",
    "datetime": "2020-11-01 17:34:52",
    "code": "600222"
  },
  {
    "title": "太龙药业：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/31004031177935.shtml",
    "datetime": "2020-10-31 00:40:18",
    "code": "600222"
  },
  {
    "title": "[太龙药业]后疫情时代为中医药注入“创新”活水!",
    "href": "http://stock.jrj.com.cn/2020/10/19000031551480.shtml",
    "datetime": "2020-10-19 00:00:00",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)发布员工持股计划 持股计划规模共计2790.17万股",
    "href": "http://stock.jrj.com.cn/2020/09/28180830854431.shtml",
    "datetime": "2020-09-28 18:08:35",
    "code": "600222"
  },
  {
    "title": "太龙药业：第八届董事会第九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/09/12001130733278.shtml",
    "datetime": "2020-09-12 00:11:09",
    "code": "600222"
  },
  {
    "title": "太龙药业：召开2020年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/09/12001130733277.shtml",
    "datetime": "2020-09-12 00:11:09",
    "code": "600222"
  },
  {
    "title": "太龙药业(600222.SH)拟推员工持股计划",
    "href": "http://stock.jrj.com.cn/2020/09/11181630731657.shtml",
    "datetime": "2020-09-11 18:16:16",
    "code": "600222"
  },
  {
    "title": "太龙药业2020年上半年净利2818万增长7% 双黄连口服液系列销售大幅增长",
    "href": "http://stock.jrj.com.cn/2020/08/22080430562070.shtml",
    "datetime": "2020-08-22 08:04:33",
    "code": "600222"
  },
  {
    "title": "太龙药业上半年业绩稳步增长 引入京港基金以1.3亿元投资新领先",
    "href": "http://stock.jrj.com.cn/2020/08/21182030558828.shtml",
    "datetime": "2020-08-21 18:20:38",
    "code": "600222"
  },
  {
    "title": "太龙药业旗下桐君堂成立中药饮片追溯系统及在线平台",
    "href": "http://stock.jrj.com.cn/2020/07/06215230156024.shtml",
    "datetime": "2020-07-06 21:52:16",
    "code": "600222"
  },
  {
    "title": "[太龙药业]法治激荡中医药振兴的磅礴力量",
    "href": "http://stock.jrj.com.cn/2020/07/03000031822682.shtml",
    "datetime": "2020-07-03 00:00:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：2020年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/06/11224029902412.shtml",
    "datetime": "2020-06-11 22:40:01",
    "code": "600222"
  },
  {
    "title": "太龙药业：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/06/08233029874768.shtml",
    "datetime": "2020-06-08 23:30:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：关于召开2020年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/05/26221029770914.shtml",
    "datetime": "2020-05-26 22:10:21",
    "code": "600222"
  },
  {
    "title": "太龙药业：第八届董事会第七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/26221029770912.shtml",
    "datetime": "2020-05-26 22:10:20",
    "code": "600222"
  },
  {
    "title": "太龙药业第一季度盈利3739.76万同比增长190.28% 中药口服液销售大幅增加",
    "href": "http://stock.jrj.com.cn/2020/04/29133029417922.shtml",
    "datetime": "2020-04-29 13:30:40",
    "code": "600222"
  },
  {
    "title": "太龙药业及分子公司自2020年3月17日以来收到政府补助534万元",
    "href": "http://stock.jrj.com.cn/2020/04/10203229259473.shtml",
    "datetime": "2020-04-10 20:32:48",
    "code": "600222"
  },
  {
    "title": "太龙药业：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/03/28001029131289.shtml",
    "datetime": "2020-03-28 00:10:10",
    "code": "600222"
  },
  {
    "title": "太龙药业：第八届董事会第五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/28001029131290.shtml",
    "datetime": "2020-03-28 00:10:10",
    "code": "600222"
  },
  {
    "title": "太龙药业2019年扣非净利润2886.01万元，实现扭亏为盈",
    "href": "http://stock.jrj.com.cn/2020/03/27214029130249.shtml",
    "datetime": "2020-03-27 21:40:06",
    "code": "600222"
  },
  {
    "title": "太龙药业：2019年度净利4571万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2020/03/27183329129056.shtml",
    "datetime": "2020-03-27 18:33:54",
    "code": "600222"
  },
  {
    "title": "太龙药业：2019年净利4571万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2020/03/27180329128907.shtml",
    "datetime": "2020-03-27 18:03:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：2019年净利实现扭亏转盈",
    "href": "http://stock.jrj.com.cn/2020/03/27175529128804.shtml",
    "datetime": "2020-03-27 17:55:57",
    "code": "600222"
  },
  {
    "title": "太龙药业2月至3月合计收到政府补助461万元",
    "href": "http://stock.jrj.com.cn/2020/03/16194029034833.shtml",
    "datetime": "2020-03-16 19:40:56",
    "code": "600222"
  },
  {
    "title": "太龙药业：收到政府补助460.56万元",
    "href": "http://stock.jrj.com.cn/2020/03/16161929033158.shtml",
    "datetime": "2020-03-16 16:19:41",
    "code": "600222"
  },
  {
    "title": "太龙药业收到政府补助136万元",
    "href": "http://stock.jrj.com.cn/2020/02/29152428919882.shtml",
    "datetime": "2020-02-29 15:24:16",
    "code": "600222"
  },
  {
    "title": "太龙药业：捐赠价值600万元药品支持疫情防控 股东拟减持不超过600万股",
    "href": "http://stock.jrj.com.cn/2020/02/03215428758126.shtml",
    "datetime": "2020-02-03 21:54:16",
    "code": "600222"
  },
  {
    "title": "太龙药业：股东拟减持不超1.05%股份",
    "href": "http://stock.jrj.com.cn/2020/02/03211528757957.shtml",
    "datetime": "2020-02-03 21:15:55",
    "code": "600222"
  },
  {
    "title": "太龙药业一字涨停 股东拟减持不超1.05%股份",
    "href": "http://stock.jrj.com.cn/2020/02/03205728757919.shtml",
    "datetime": "2020-02-03 20:57:00",
    "code": "600222"
  },
  {
    "title": "太龙药业紧急捐赠价值520万元双黄连口服液到疫区",
    "href": "http://stock.jrj.com.cn/2020/02/02130228748369.shtml",
    "datetime": "2020-02-02 13:02:00",
    "code": "600222"
  },
  {
    "title": "太龙药业相关负责人回应“双黄连口服液可抑制新冠病毒”",
    "href": "http://stock.jrj.com.cn/2020/02/01095428746482.shtml",
    "datetime": "2020-02-01 09:54:29",
    "code": "600222"
  },
  {
    "title": "太龙药业相关负责人回应“双黄连口服液可抑制新冠病毒”",
    "href": "http://stock.jrj.com.cn/2020/02/01093628746445.shtml",
    "datetime": "2020-02-01 09:36:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：2019年年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2020/01/22100028718846.shtml",
    "datetime": "2020-01-22 10:00:02",
    "code": "600222"
  },
  {
    "title": "太龙药业：2019年年度业绩预盈公告",
    "href": "http://stock.jrj.com.cn/2020/01/22002028715794.shtml",
    "datetime": "2020-01-22 00:20:04",
    "code": "600222"
  },
  {
    "title": "太龙药业2019年度预计盈利4200万元至5000万元",
    "href": "http://stock.jrj.com.cn/2020/01/21214628715378.shtml",
    "datetime": "2020-01-21 21:46:01",
    "code": "600222"
  },
  {
    "title": "太龙药业连续涨停 公司称外部环境未发生重大变化",
    "href": "http://stock.jrj.com.cn/2020/01/21204328715075.shtml",
    "datetime": "2020-01-21 20:43:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：预计2019年扭亏为盈 净利润4200万元-5000万元",
    "href": "http://stock.jrj.com.cn/2020/01/21202328715026.shtml",
    "datetime": "2020-01-21 20:23:06",
    "code": "600222"
  },
  {
    "title": "太龙药业董事陶新华辞职 2018年薪酬为100万元",
    "href": "http://stock.jrj.com.cn/2019/11/18180028413678.shtml",
    "datetime": "2019-11-18 18:00:12",
    "code": "600222"
  },
  {
    "title": "太龙药业前三季度净利润同比增长482.9%",
    "href": "http://stock.jrj.com.cn/2019/10/25221728302660.shtml",
    "datetime": "2019-10-25 22:17:19",
    "code": "600222"
  },
  {
    "title": "太龙药业前三季净利增长483%",
    "href": "http://stock.jrj.com.cn/2019/10/25172528301005.shtml",
    "datetime": "2019-10-25 17:25:32",
    "code": "600222"
  },
  {
    "title": "太龙药业前三季度盈利3291万 同比增长483%",
    "href": "http://stock.jrj.com.cn/2019/10/25171928300946.shtml",
    "datetime": "2019-10-25 17:19:55",
    "code": "600222"
  },
  {
    "title": "太龙药业：2019年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/09/09224028111523.shtml",
    "datetime": "2019-09-09 22:40:04",
    "code": "600222"
  },
  {
    "title": "太龙药业：第八届董事会第一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/09/09224028111524.shtml",
    "datetime": "2019-09-09 22:40:04",
    "code": "600222"
  },
  {
    "title": "太龙药业收到2019年失业保险应急稳岗返还补贴464.2万元",
    "href": "http://stock.jrj.com.cn/2019/09/05080728092160.shtml",
    "datetime": "2019-09-05 08:07:38",
    "code": "600222"
  },
  {
    "title": "太龙药业：近日收到政府补助464万元",
    "href": "http://stock.jrj.com.cn/2019/09/04220228090448.shtml",
    "datetime": "2019-09-04 22:02:24",
    "code": "600222"
  },
  {
    "title": "太龙药业：收到政府补助464万元",
    "href": "http://stock.jrj.com.cn/2019/09/04162728088616.shtml",
    "datetime": "2019-09-04 16:27:54",
    "code": "600222"
  },
  {
    "title": "太龙药业累计收到政府补助约170万元",
    "href": "http://stock.jrj.com.cn/2019/08/29102928054382.shtml",
    "datetime": "2019-08-29 10:29:22",
    "code": "600222"
  },
  {
    "title": "太龙药业选举温太祥代表职工担任第八届监事会职工监事",
    "href": "http://stock.jrj.com.cn/2019/08/24175728027147.shtml",
    "datetime": "2019-08-24 17:57:06",
    "code": "600222"
  },
  {
    "title": "太龙药业上半年净利润较上年同期增长848.78%",
    "href": "http://stock.jrj.com.cn/2019/08/23235828025780.shtml",
    "datetime": "2019-08-23 23:58:13",
    "code": "600222"
  },
  {
    "title": "太龙药业：关于召开2019年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/08/23222028025424.shtml",
    "datetime": "2019-08-23 22:20:08",
    "code": "600222"
  },
  {
    "title": "太龙药业：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/23222028025422.shtml",
    "datetime": "2019-08-23 22:20:07",
    "code": "600222"
  },
  {
    "title": "太龙药业：第七届董事会第二十二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/23222028025423.shtml",
    "datetime": "2019-08-23 22:20:07",
    "code": "600222"
  },
  {
    "title": "太龙药业2019年上半年净利2622万 营运资产增加",
    "href": "http://stock.jrj.com.cn/2019/08/23155928023122.shtml",
    "datetime": "2019-08-23 15:59:36",
    "code": "600222"
  },
  {
    "title": "[太龙药业]国务院印发实施健康中国行动的意见和考核方案",
    "href": "http://stock.jrj.com.cn/2019/07/24000028064202.shtml",
    "datetime": "2019-07-24 00:00:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：已耗资1.05亿元回购4.11%股份",
    "href": "http://stock.jrj.com.cn/2019/07/01164427778871.shtml",
    "datetime": "2019-07-01 16:44:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：非公开发行限售股上市流通的公告",
    "href": "http://stock.jrj.com.cn/2019/05/13220027565564.shtml",
    "datetime": "2019-05-13 22:00:02",
    "code": "600222"
  },
  {
    "title": "太龙药业：已累计耗资1.05亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/05/09172927548824.shtml",
    "datetime": "2019-05-09 17:29:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：已累计回购4.11%股份 耗资1.05亿元",
    "href": "http://stock.jrj.com.cn/2019/05/09171427548655.shtml",
    "datetime": "2019-05-09 17:14:02",
    "code": "600222"
  },
  {
    "title": "太龙药业：已累计回购3.72%股份 耗资9402万元",
    "href": "http://stock.jrj.com.cn/2019/05/07161927537732.shtml",
    "datetime": "2019-05-07 16:19:00",
    "code": "600222"
  },
  {
    "title": "太龙药业一季度净利1288万元同比增长520% 现金流量净额为-1951万元",
    "href": "http://stock.jrj.com.cn/2019/04/30194227515634.shtml",
    "datetime": "2019-04-30 19:42:26",
    "code": "600222"
  },
  {
    "title": "太龙药业：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/20002027431172.shtml",
    "datetime": "2019-04-20 00:20:02",
    "code": "600222"
  },
  {
    "title": "投服中心发问太龙药业资产出售：公司3.19亿元去了哪里",
    "href": "http://stock.jrj.com.cn/2019/04/14232827396444.shtml",
    "datetime": "2019-04-14 23:28:41",
    "code": "600222"
  },
  {
    "title": "投服中心：太龙药业资产出售 资产评估机构是否“怠工”？",
    "href": "http://stock.jrj.com.cn/2019/04/14180727396217.shtml",
    "datetime": "2019-04-14 18:07:00",
    "code": "600222"
  },
  {
    "title": "太龙药业去年净利由盈转亏 事长李景亮年薪91.67万元",
    "href": "http://stock.jrj.com.cn/2019/04/01194527296305.shtml",
    "datetime": "2019-04-01 19:45:36",
    "code": "600222"
  },
  {
    "title": "太龙药业：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/03/30033027270538.shtml",
    "datetime": "2019-03-30 03:30:06",
    "code": "600222"
  },
  {
    "title": "太龙药业：第七届董事会第十九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/03/30033027270539.shtml",
    "datetime": "2019-03-30 03:30:06",
    "code": "600222"
  },
  {
    "title": "太龙药业：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/03/30033027270540.shtml",
    "datetime": "2019-03-30 03:30:06",
    "code": "600222"
  },
  {
    "title": "太龙药业2018年营业收入11.95亿元 同比增长2.26%",
    "href": "http://stock.jrj.com.cn/2019/03/29212727269162.shtml",
    "datetime": "2019-03-29 21:27:46",
    "code": "600222"
  },
  {
    "title": "太龙药业已回购659万元公司股份 成交最高价为3.71元/股",
    "href": "http://stock.jrj.com.cn/2019/02/12183427035140.shtml",
    "datetime": "2019-02-12 18:34:18",
    "code": "600222"
  },
  {
    "title": "太龙药业：首次回购180万股 耗资659万元",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/12080027032691.shtml",
    "datetime": "2019-02-12 08:00:02",
    "code": "600222"
  },
  {
    "title": "太龙药业：首次回购659万元股份",
    "href": "http://stock.jrj.com.cn/2019/02/11204527029448.shtml",
    "datetime": "2019-02-11 20:45:00",
    "code": "600222"
  },
  {
    "title": "太龙药业回购金额由至少2000万元上调为至少1.25亿元",
    "href": "http://stock.jrj.com.cn/2019/01/31213627009713.shtml",
    "datetime": "2019-01-31 21:36:42",
    "code": "600222"
  },
  {
    "title": "太龙药业回购金额由至少2000万元上修为至少1.25亿元",
    "href": "http://stock.jrj.com.cn/2019/01/31172527008719.shtml",
    "datetime": "2019-01-31 17:25:41",
    "code": "600222"
  },
  {
    "title": "太龙药业：2018年年度业绩预亏公告",
    "href": "http://stock.jrj.com.cn/2019/01/25224026982750.shtml",
    "datetime": "2019-01-25 22:40:06",
    "code": "600222"
  },
  {
    "title": "太龙药业：第七届董事会第十七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/01/25224026982749.shtml",
    "datetime": "2019-01-25 22:40:06",
    "code": "600222"
  },
  {
    "title": "太龙药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/25203026982192.shtml",
    "datetime": "2019-01-25 20:30:00",
    "code": "600222"
  },
  {
    "title": "停产已4年 太龙药业子公司注销药品生产许可证",
    "href": "http://stock.jrj.com.cn/2019/01/04001026849269.shtml",
    "datetime": "2019-01-04 00:10:11",
    "code": "600222"
  },
  {
    "title": "[太龙药业]换季的时候为什么容易出现心脏病",
    "href": "http://stock.jrj.com.cn/2019/01/02000027153639.shtml",
    "datetime": "2019-01-02 00:00:00",
    "code": "600222"
  },
  {
    "title": "太龙药业收到政府补助107万元",
    "href": "http://stock.jrj.com.cn/2018/12/26173026806984.shtml",
    "datetime": "2018-12-26 17:30:06",
    "code": "600222"
  },
  {
    "title": "[太龙药业]肝脏受损后,晨起时会有4个表现",
    "href": "http://stock.jrj.com.cn/2018/12/19000027153631.shtml",
    "datetime": "2018-12-19 00:00:00",
    "code": "600222"
  },
  {
    "title": "[太龙药业]会吃豆,胜过肉,吃6种\"养生豆\"对身体大有好处!",
    "href": "http://stock.jrj.com.cn/2018/12/13000027153635.shtml",
    "datetime": "2018-12-13 00:00:00",
    "code": "600222"
  },
  {
    "title": "[太龙药业]“世界中医药日”诞生!未来中医药产业将蓬勃发展",
    "href": "http://stock.jrj.com.cn/2018/11/28000026779820.shtml",
    "datetime": "2018-11-28 00:00:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：2018年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/11/26220025410825.shtml",
    "datetime": "2018-11-26 22:00:12",
    "code": "600222"
  },
  {
    "title": "太龙药业：拟斥资0.2亿至2.5亿元回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/09075925321764.shtml",
    "datetime": "2018-11-09 07:59:58",
    "code": "600222"
  },
  {
    "title": "太龙药业：关于召开2018年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/11/08233025320476.shtml",
    "datetime": "2018-11-08 23:30:01",
    "code": "600222"
  },
  {
    "title": "太龙药业：第七届董事会第十四次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/11/08233025320474.shtml",
    "datetime": "2018-11-08 23:30:01",
    "code": "600222"
  },
  {
    "title": "太龙药业：拟2000万至2.5亿元回购股份",
    "href": "http://stock.jrj.com.cn/2018/11/08184125319816.shtml",
    "datetime": "2018-11-08 18:41:00",
    "code": "600222"
  },
  {
    "title": "[太龙药业]全国中药材生产形势概况",
    "href": "http://stock.jrj.com.cn/2018/10/29000026779821.shtml",
    "datetime": "2018-10-29 00:00:00",
    "code": "600222"
  },
  {
    "title": "[太龙药业]太龙双黄连口服液荣获2017-2018年度中国药店感冒药类店员推荐率最高品牌",
    "href": "http://stock.jrj.com.cn/2018/10/25000026779822.shtml",
    "datetime": "2018-10-25 00:00:00",
    "code": "600222"
  },
  {
    "title": "[太龙药业]第七届药祖桐君中医药文化节在浙江桐庐开幕",
    "href": "http://stock.jrj.com.cn/2018/10/22000026779819.shtml",
    "datetime": "2018-10-22 00:00:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：2018年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/09/05232025052442.shtml",
    "datetime": "2018-09-05 23:20:00",
    "code": "600222"
  },
  {
    "title": "[太龙药业]再见CFDA!国家药监局英文简称改为NMPA",
    "href": "http://stock.jrj.com.cn/2018/09/03000026779818.shtml",
    "datetime": "2018-09-03 00:00:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/17224024968468.shtml",
    "datetime": "2018-08-17 22:40:02",
    "code": "600222"
  },
  {
    "title": "太龙药业：第七届董事会第十二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/08/17224024968469.shtml",
    "datetime": "2018-08-17 22:40:02",
    "code": "600222"
  },
  {
    "title": "太龙药业：关于召开2018年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/08/17224024968470.shtml",
    "datetime": "2018-08-17 22:40:02",
    "code": "600222"
  },
  {
    "title": "太龙药业收到政府补助110万元",
    "href": "http://stock.jrj.com.cn/2018/08/06180924911771.shtml",
    "datetime": "2018-08-06 18:09:04",
    "code": "600222"
  },
  {
    "title": "太龙药业：2017年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2018/05/29224024607517.shtml",
    "datetime": "2018-05-29 22:40:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：乳结消颗粒获临床试验批件",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/28080024597306.shtml",
    "datetime": "2018-05-28 08:00:02",
    "code": "600222"
  },
  {
    "title": "太龙药业收到政府补助225万元",
    "href": "http://stock.jrj.com.cn/2018/05/23174424580416.shtml",
    "datetime": "2018-05-23 17:44:14",
    "code": "600222"
  },
  {
    "title": "太龙药业：非公开发行限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2018/05/11221024529224.shtml",
    "datetime": "2018-05-11 22:10:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：2017年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/21000024425464.shtml",
    "datetime": "2018-04-21 00:00:34",
    "code": "600222"
  },
  {
    "title": "太龙药业：第七届董事会第十次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/21000024425463.shtml",
    "datetime": "2018-04-21 00:00:33",
    "code": "600222"
  },
  {
    "title": "[天眼]太龙药业间接控股股东遭监管 股权转让重大进展未告知",
    "href": "http://stock.jrj.com.cn/2018/02/09195524095729.shtml",
    "datetime": "2018-02-09 19:55:04",
    "code": "600222"
  },
  {
    "title": "太龙药业收到政府补贴252.8万元",
    "href": "http://stock.jrj.com.cn/2017/12/06155523750670.shtml",
    "datetime": "2017-12-06 15:55:16",
    "code": "600222"
  },
  {
    "title": "实控人股权转让疑点重重 上交所追问太龙药业详情",
    "href": "http://stock.jrj.com.cn/2017/03/21035722202515.shtml",
    "datetime": "2017-03-21 03:57:25",
    "code": "600222"
  },
  {
    "title": "太龙药业玩产业基金 药企频涉资本平台",
    "href": "http://stock.jrj.com.cn/2015/04/10025919080837.shtml",
    "datetime": "2015-04-10 02:59:25",
    "code": "600222"
  },
  {
    "title": "太龙药业：与河南中医学院签订中医药战略合作框架协议",
    "href": "http://stock.jrj.com.cn/hotstock/2015/04/08075919070669.shtml",
    "datetime": "2015-04-08 07:59:53",
    "code": "600222"
  },
  {
    "title": "太龙药业逐步对主业进行分版块管理",
    "href": "http://stock.jrj.com.cn/2014/12/26202818610829.shtml",
    "datetime": "2014-12-26 20:28:08",
    "code": "600222"
  },
  {
    "title": "太龙药业拟购买两公司股权",
    "href": "http://stock.jrj.com.cn/2014/07/02012217525725.shtml",
    "datetime": "2014-07-02 01:22:51",
    "code": "600222"
  },
  {
    "title": "太龙药业重组细节尚需完善 继续停牌",
    "href": "http://stock.jrj.com.cn/2014/07/01161417523718.shtml",
    "datetime": "2014-07-01 16:14:00",
    "code": "600222"
  },
  {
    "title": "太龙药业一季度净利442万 降13%",
    "href": "http://stock.jrj.com.cn/invest/2014/04/25155517112403.shtml",
    "datetime": "2014-04-25 15:55:00",
    "code": "600222"
  },
  {
    "title": "太龙药业：2013年半年度业绩预增的公告",
    "href": "http://stock.jrj.com.cn/2013/07/11212015518190.shtml",
    "datetime": "2013-07-11 21:20:02",
    "code": "600222"
  },
  {
    "title": "太龙药业会计游戏虚增利润 助力再融资",
    "href": "http://stock.jrj.com.cn/2013/05/24101715334318.shtml",
    "datetime": "2013-05-24 10:17:09",
    "code": "600222"
  },
  {
    "title": "太龙药业：拟定向增发募资4亿元",
    "href": "http://stock.jrj.com.cn/2012/04/05103912662715.shtml",
    "datetime": "2012-04-05 10:39:45",
    "code": "600222"
  },
  {
    "title": "太龙药业多赚30% 10送1转2派0.12元",
    "href": "http://stock.jrj.com.cn/2010/03/1922057144806.shtml",
    "datetime": "2010-03-19 22:05:57",
    "code": "600222"
  }
]